Behbahani Ali bought CRSP
September 17, 2026 · Form 4 insider transaction
Behbahani Ali bought 30,000 shares of CRISPR Therapeutics AG at $14.00 per share, a transaction worth $420.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$14.00
Total value
$420.0K
InsiderBehbahani Ali
RoleDirector, 10% owner
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateSeptember 17, 2026
Filing dateSeptember 21, 2026
Shares owned after30,316
OwnershipDirect
10b5-1 planNo
AmendedNo